Price $83.89 |
Market Cap
147.77B
|
Sector Health Care |
Div. Growth
6.40%
|
|
P/E
44.7
|
P/B
4.61
|
P/S
4.66
|
Dividend %
1.50%
|
|
P/CF
-
|
P/FCF
61.0
|
Op. Cash Flow
5.9M
|
FCF
1.3
|
|
Op. Margin
11.60%
|
Net Margin
8.40%
|
ROE
8.50%
|
ROI
6.10%
|
|
ROA
3.80%
|
EPS Growth
182.30%
|
Current Ratio
1.6
|
Debt/Equity
63.40%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Zimmer Biomet Holdings Inc (ZBH) | $142.57 | - | 0.70% | 28.38B | Strong Buy |
| Novelion Therapeutics Inc (USA (NVLNF) | $0.70 | - | - | 13.1M | Strong Buy |
| Novan Inc (NOVN) | $1.98 | - | - | 57.4M | Strong Buy |
| Natus Medical Inc (NTUS) | $31.69 | - | - | 1.15B | Strong Buy |
| MTBC Inc (MTBC) | $3.94 | - | - | 43.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
